Barium titanate nanoparticles: Highly cytocompatible dispersions in glycol-chitosan and doxorubicin complexes for cancer therapy

Nanoscale Research Letters

Volumn 5, Issue 7, 2010, Pages 1093-1101

  Ciofani, Gianni ^a   Danti, Serena ^b   D'Alessandro, Delfo ^b   Moscato, Stefania ^b   Petrini, Mario ^b   Menciassi, Arianna ^a,c  

^a ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

Barium titanate nanoparticles; Cancer therapy; Doxorubicin; Glycol chitosan; Neuroblastoma

Indexed keywords

BARIUM TITANATE NANOPARTICLES; CANCER THERAPY; DOXORUBICIN; GLYCOL CHITOSAN; NEUROBLASTOMAS;

BARIUM TITANATE; BINDING ENERGY; CERAMIC MATERIALS; CHEMOTHERAPY; CHITOSAN; DISPERSIONS; GLYCOLS; NANOSTRUCTURED MATERIALS; ONCOLOGY;

NANOPARTICLES;

EID: 79951839419     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1007/s11671-010-9607-0     Document Type: Article

References (30)

1. O.M. Koo, I. Rubinstein, H. Onyuksel, Nanomedicine: NBM 1, 193 (2005)
2. M.L. Forrest, G.S. Kwon, Adv. Drug Deliv. Rev. 60, 861 (2008)
3. M.M. Amiji, Nanomedicine: NBM 2, 299 (2006)
4. J. Wood, Doxorubicin, in The cytotoxic Handbook, 4th edn., ed. by M. Allwood, A. Stanley, P. Wright (Radcliffe Medical Press Ltd, Oxon, UK, 2002), pp. 322-329
5. L.B. Liao, H.Y. Zhou, X.M. Xiao, J. Mol. Struct. 749, 108 (2005)
6. A.B. Anderson, J. Gergen, E.A. Arriaga, J. Chromatogr B 769, 97 (2002)
7. L.C. Kremer, E.C. van Dalen, P.A. Voute, P.A. Ann, Oncology 13, 503 (2002)
8. A. Longhi, S. Ferrari, G. Bacci, S. Specchia, Anticancer Drugs 18, 737 (2007)
9. P. Elliott, Semin. Oncol. 33, S2 (2006)
10. Ortho-Biotech. DOXIL®-Doxorubicin HCL liposome injection ortho-biotech, http://www.orthobiotech.com/
11. D. Lorusso, A. Di Stefano, V. Carone, A. Fagotti, S. Pisconti, G. Scambia, G. Ann, Oncology 18, 1159 (2007)
12. H.D. Dorfman, B. Czerniak, Cancer 75, 203 (1995)
13. M.L. Tan, A.M. Friedhuber, D.E. Dunstan, P.F.M. Choong, C.R. Dass, Biomaterials 31, 541 (2010)
14. K.J. Longmuir, S.M. Haynes, J.L. Baratta, N. Kasabwalla, R.T. Robertson, Int. J. Pharm. 382, 222 (2009)
15. J. Park, P.M. Fong, J. Lu, K.S. Russell, C.J. Booth, W.M. Saltzman, T.M. Fahmy, Nanomedicine: NBM 5, 400 (2009)
16. J.R. Eisenbrey, O. Mualem Burstein, R. Kambhampati, F. Forsberg, J.B. Liu, M.A. Wheatley, J. Control. Release doi: 10.1016/j.jconrel.2009.12.021
17. D. Hennings, C. Metzmacher, B. Schreinemacher, J. Am. Ceram. Soc. 84, 179 (2001)
18. M. Buscaglia, V. Buscaglia, M. Viviani, N. Nanni, M. Hanuskova, Eur. Ceram. Soc. 20, 1997 (2999)
19. G. Ciofani, S. Danti, S. Moscato, L. Albertazzi, D. D'Alessandro, D. Dinucci, F. Chiellini, M. Petrini, A. Menciassi, Colloid. Surface B 76, 535 (2010)
20. J.M. Yu, Y.J. Li, L.Y. Qiu, Y. Jin, Eur. Polym. J. 44, 555 (2008)
21. Y.J. Son, J.S. Jang, Y.W. Cho, H. Chung, R.W. Park, I.C. Kwon, I.S. Kim, J.Y. Park, S.B. Seo, C.R. Park, S.Y. Jeong, J. Control. Release 91, 135 (2003)
22. E.S. Lee, K.H. Park, I.S. Park, K. Na, Int. J. Pharm. 338, 310 (2007)
23. A. Trapani, J. Sitterberg, U. Bakowsky, T. Kissel, Int. J. Pharm 375, 97 (2009)
24. S.J. Martin, C.P. Reutelingsperger, A.J. McGahon, J.A. Rader, R.C.A.A. van Schie, D.M. LaFace, D.R. Green, J. Exp. Med. 182, 1545 (1995)
25. K. Pulskamp, S. Diabatè, H.F. Krug, Toxicol. Lett. 168, 58 (2007)
26. E.J. Park, J. Choi, Y.K. Park, K. Park, Toxicology 245, 90 (2008)
27. H. Ali-Boucetta, K.T. Al-Jamal, D. McCarthy, M. Prato, A. Bianco, K. Kostarelos, Chem. Commun. 4, 459 (2008)
28. Z. Liu, X. Sun, N. Nakayama-Ratchford, H. Dai, ACS Nano 1, 50 (2007)
29. L. Belyanskaya, S. Weigel, C. Hirsch, U. Tobler, H.F. Krug, P. Wick, Neurotoxicology 30, 702 (2009)
30. G. Bardi, P. Tognini, G. Ciofani, V. Raffa, M. Costa, T. Pizzorusso, Nanomedicine: NBM 5, 96 (2009)